Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells

C. Devito, K. Broliden, R. Kaul, L. Svensson, K. Johansen, P. Kiama, J. Kimani, L. Lopalco, S. Piconi, J. J. Bwayo, F. Plummer, M. Clerici, J. Hinkula

Research output: Contribution to journalArticle

197 Citations (Scopus)

Abstract

HIV-1-specific IgA has been described in the genital tract and plasma of HIV-1 highly exposed, persistently seronegative (HEPS) individuals, and IgA from these sites has been shown to neutralize HIV-1. This study examines the ability of IgA isolated from HEPS individuals to inhibit transcytosis across a tight epithelial cell layer. A Transwell system was established to model HIV-1 infection across the human mucosal epithelium. The apical-basolateral transcytosis of primary HIV-1 isolates across this mucosal model was examined in the presence and the absence of IgA isolated from the genital tract, saliva, and plasma of HEPS individuals enrolled in both a sex worker cohort in Nairobi, Kenya, and a discordant couple cohort in Italy. In the absence of IgA, HIV-1 primary isolates were actively transported across the epithelial membrane and were released on the opposite side of the barrier. These transcytosed HIV-1 particles retained their ability to infect human mononuclear cells. However, IgA purified from the mucosa and plasma of HEPS individuals was able to inhibit HIV-1 transcytosis. Inhibition was seen in three of six cervicovaginal fluid samples, five of 10 saliva samples, and three of six plasma samples against at least one of the two primary HIV-1 isolates tested. IgA from low risk, healthy control subjects had no inhibitory effect on HIV-1 transcytosis. The ability of mucosal and plasma IgA to inhibit HIV-1 transcytosis across the mucosal epithelium may represent an important mechanism for protection against the sexual acquisition of HIV-1 infection in HEPS individuals.

Original languageEnglish
Pages (from-to)5170-5176
Number of pages7
JournalJournal of Immunology
Volume165
Issue number9
Publication statusPublished - Nov 1 2000

Fingerprint

Transcytosis
Immunoglobulin A
HIV-1
Epithelial Cells
Saliva
HIV Infections
Epithelium
Sex Workers
Kenya
Italy
Healthy Volunteers
Mucous Membrane

ASJC Scopus subject areas

  • Immunology

Cite this

Devito, C., Broliden, K., Kaul, R., Svensson, L., Johansen, K., Kiama, P., ... Hinkula, J. (2000). Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. Journal of Immunology, 165(9), 5170-5176.

Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. / Devito, C.; Broliden, K.; Kaul, R.; Svensson, L.; Johansen, K.; Kiama, P.; Kimani, J.; Lopalco, L.; Piconi, S.; Bwayo, J. J.; Plummer, F.; Clerici, M.; Hinkula, J.

In: Journal of Immunology, Vol. 165, No. 9, 01.11.2000, p. 5170-5176.

Research output: Contribution to journalArticle

Devito, C, Broliden, K, Kaul, R, Svensson, L, Johansen, K, Kiama, P, Kimani, J, Lopalco, L, Piconi, S, Bwayo, JJ, Plummer, F, Clerici, M & Hinkula, J 2000, 'Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells', Journal of Immunology, vol. 165, no. 9, pp. 5170-5176.
Devito C, Broliden K, Kaul R, Svensson L, Johansen K, Kiama P et al. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. Journal of Immunology. 2000 Nov 1;165(9):5170-5176.
Devito, C. ; Broliden, K. ; Kaul, R. ; Svensson, L. ; Johansen, K. ; Kiama, P. ; Kimani, J. ; Lopalco, L. ; Piconi, S. ; Bwayo, J. J. ; Plummer, F. ; Clerici, M. ; Hinkula, J. / Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. In: Journal of Immunology. 2000 ; Vol. 165, No. 9. pp. 5170-5176.
@article{79824b3b47264fb28065ec4eb7d1842c,
title = "Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells",
abstract = "HIV-1-specific IgA has been described in the genital tract and plasma of HIV-1 highly exposed, persistently seronegative (HEPS) individuals, and IgA from these sites has been shown to neutralize HIV-1. This study examines the ability of IgA isolated from HEPS individuals to inhibit transcytosis across a tight epithelial cell layer. A Transwell system was established to model HIV-1 infection across the human mucosal epithelium. The apical-basolateral transcytosis of primary HIV-1 isolates across this mucosal model was examined in the presence and the absence of IgA isolated from the genital tract, saliva, and plasma of HEPS individuals enrolled in both a sex worker cohort in Nairobi, Kenya, and a discordant couple cohort in Italy. In the absence of IgA, HIV-1 primary isolates were actively transported across the epithelial membrane and were released on the opposite side of the barrier. These transcytosed HIV-1 particles retained their ability to infect human mononuclear cells. However, IgA purified from the mucosa and plasma of HEPS individuals was able to inhibit HIV-1 transcytosis. Inhibition was seen in three of six cervicovaginal fluid samples, five of 10 saliva samples, and three of six plasma samples against at least one of the two primary HIV-1 isolates tested. IgA from low risk, healthy control subjects had no inhibitory effect on HIV-1 transcytosis. The ability of mucosal and plasma IgA to inhibit HIV-1 transcytosis across the mucosal epithelium may represent an important mechanism for protection against the sexual acquisition of HIV-1 infection in HEPS individuals.",
author = "C. Devito and K. Broliden and R. Kaul and L. Svensson and K. Johansen and P. Kiama and J. Kimani and L. Lopalco and S. Piconi and Bwayo, {J. J.} and F. Plummer and M. Clerici and J. Hinkula",
year = "2000",
month = "11",
day = "1",
language = "English",
volume = "165",
pages = "5170--5176",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "9",

}

TY - JOUR

T1 - Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells

AU - Devito, C.

AU - Broliden, K.

AU - Kaul, R.

AU - Svensson, L.

AU - Johansen, K.

AU - Kiama, P.

AU - Kimani, J.

AU - Lopalco, L.

AU - Piconi, S.

AU - Bwayo, J. J.

AU - Plummer, F.

AU - Clerici, M.

AU - Hinkula, J.

PY - 2000/11/1

Y1 - 2000/11/1

N2 - HIV-1-specific IgA has been described in the genital tract and plasma of HIV-1 highly exposed, persistently seronegative (HEPS) individuals, and IgA from these sites has been shown to neutralize HIV-1. This study examines the ability of IgA isolated from HEPS individuals to inhibit transcytosis across a tight epithelial cell layer. A Transwell system was established to model HIV-1 infection across the human mucosal epithelium. The apical-basolateral transcytosis of primary HIV-1 isolates across this mucosal model was examined in the presence and the absence of IgA isolated from the genital tract, saliva, and plasma of HEPS individuals enrolled in both a sex worker cohort in Nairobi, Kenya, and a discordant couple cohort in Italy. In the absence of IgA, HIV-1 primary isolates were actively transported across the epithelial membrane and were released on the opposite side of the barrier. These transcytosed HIV-1 particles retained their ability to infect human mononuclear cells. However, IgA purified from the mucosa and plasma of HEPS individuals was able to inhibit HIV-1 transcytosis. Inhibition was seen in three of six cervicovaginal fluid samples, five of 10 saliva samples, and three of six plasma samples against at least one of the two primary HIV-1 isolates tested. IgA from low risk, healthy control subjects had no inhibitory effect on HIV-1 transcytosis. The ability of mucosal and plasma IgA to inhibit HIV-1 transcytosis across the mucosal epithelium may represent an important mechanism for protection against the sexual acquisition of HIV-1 infection in HEPS individuals.

AB - HIV-1-specific IgA has been described in the genital tract and plasma of HIV-1 highly exposed, persistently seronegative (HEPS) individuals, and IgA from these sites has been shown to neutralize HIV-1. This study examines the ability of IgA isolated from HEPS individuals to inhibit transcytosis across a tight epithelial cell layer. A Transwell system was established to model HIV-1 infection across the human mucosal epithelium. The apical-basolateral transcytosis of primary HIV-1 isolates across this mucosal model was examined in the presence and the absence of IgA isolated from the genital tract, saliva, and plasma of HEPS individuals enrolled in both a sex worker cohort in Nairobi, Kenya, and a discordant couple cohort in Italy. In the absence of IgA, HIV-1 primary isolates were actively transported across the epithelial membrane and were released on the opposite side of the barrier. These transcytosed HIV-1 particles retained their ability to infect human mononuclear cells. However, IgA purified from the mucosa and plasma of HEPS individuals was able to inhibit HIV-1 transcytosis. Inhibition was seen in three of six cervicovaginal fluid samples, five of 10 saliva samples, and three of six plasma samples against at least one of the two primary HIV-1 isolates tested. IgA from low risk, healthy control subjects had no inhibitory effect on HIV-1 transcytosis. The ability of mucosal and plasma IgA to inhibit HIV-1 transcytosis across the mucosal epithelium may represent an important mechanism for protection against the sexual acquisition of HIV-1 infection in HEPS individuals.

UR - http://www.scopus.com/inward/record.url?scp=0034327707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034327707&partnerID=8YFLogxK

M3 - Article

C2 - 11046049

AN - SCOPUS:0034327707

VL - 165

SP - 5170

EP - 5176

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 9

ER -